Status:
UNKNOWN
Desmopressin for Bleeding Related to Low Body Temperature
Lead Sponsor:
The University of Hong Kong
Conditions:
Hypothermia Induced Impairment of Primary Haemostasis
Eligibility:
All Genders
18-50 years
Phase:
PHASE4
Brief Summary
To study, with a prospective randomised controlled design, whether the subcutaneous administration of the haemostatic drug desmopressin, may improve the impairment of primary haemostasis due to mildly...
Eligibility Criteria
Inclusion
- 1\. Healthy volunteers
Exclusion
- Any known platelet or coagulation disorder.
- Pregnant or lactating women.
- Known chronic liver or renal disease.
- Coronary artery, carotid artery or peripheral artery disease
- Recent history of taking antiplatelet drugs, anticoagulants or herbal preparations.
- Smoker or alcohol user
- Mentally incapable of providing informed consent
- Students or junior staff members who had direct working relationship with the PI
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00902057
Start Date
June 1 2009
End Date
June 1 2011
Last Update
May 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, Hong Kong, China, HKSAR